Work

Mechanistic insights into Xuebijing’s therapeutic effects on sepsis-induced cardiomyopathy: Transcriptomics-based approach combining WGCNA, machine learning, network pharmacology, and experimental validation

Year: 2026
Type: article
Abstract: Background sepsis-induced cardiomyopathy (SIC) is a critical complication of sepsis, contributing significantly to high mortality rates. The underlying molecular mechanisms remain poorly understood, and effective therapeutic strategies are urgently needed. Xuebijing (XBJ), a traditional Chinese medicine formulation, has shown potential in treating sepsis due to its anti-inflammatory and antioxidant properties. However, its specific role in regulating SIC and the key molecular targets involved have not been fully elucidated. Methods Differentially expressed genes (DEGs) between septic patients and healthy controls were identified using the GEO dataset (Series accession: GSE95233). Weighted gene co-expression network analysis (WGCNA) was employed to determine sepsis-related gene modules. Machine learning algorithms (LASSO regression, SVM-RFE, and Random Forest) were used to screen key therapeutic targets of XBJ. Functional enrichment (Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and Gene set enrichment analysis) were performed to explore biological pathways. The relative abundance of immune cell types in normal and disease samples was estimated using the CIBERSORT algorithm. Molecular docking validated the binding affinity between XBJ components and key targets. In vitro, H9C2 cells were treated with lipopolysaccharide (LPS) to simulate sepsis-induced cardiac injury, and the effects of XBJ and PADI4 overexpression on inflammation and oxidative stress were assessed by enzyme-linked immunosorbent assays, colorimetric assays, and fluorometric assay. In vivo, a cecal ligation and puncture (CLP) rat model was used to evaluate XBJ’s therapeutic efficacy. Results WGCNA identified the “MEblue” module as the most clinically significant in sepsis (r = -0.81, P = 2e-29). By intersecting XBJ component targets, DEGs, and module genes, 20 candidate genes were identified. Machine learning algorithms further narrowed these to three key genes: N-ribosyldihydronicotinamide:quinone dehydrogenase 2 (NQO2), peptidyl arginine deiminase 4 (PADI4), and protein kinase C eta (PRKCH). PADI4 showed the most significant differential expression in sepsis and strong binding affinity with XBJ components (binding energy < −6 kcal/mol). Immune infiltration analysis revealed significant alterations in immune cell populations in sepsis ( P < 0.05), with PADI4 expression correlating with neutrophil degranulation and T-cell differentiation pathways. In vitro, XBJ attenuated LPS-induced inflammation and oxidative stress in H9C2 cells ( P < 0.05), but these effects were reversed by PADI4 overexpression ( P < 0.05). In vivo, XBJ improved cardiac function (elevated ejection fraction and fractional shortening) and reduced inflammation and oxidative stress in CLP-induced sepsis rats ( P < 0.05). Conclusion XBJ ameliorated sepsis-induced cardiomyopathy by inhibiting PADI4 to suppress inflammation and oxidative stress. These findings highlight PADI4 as a potential biomarker and therapeutic target for SIC.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $2,300
OpenAlex ID: W7204668047
FWCI:
Cites: 32
Cited by:
Related to: 10